Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 2, 2009, Pages 229-234

  Torres, K C L ^a   Souza, B R ^a   Miranda, D M ^a   Sampaio, A M ^a   Nicolato, R ^a   Neves, F S ^a   Barros, A G A ^a   Dutra, W O ^a   Gollob, K J ^a   Correa, H ^a   Romano Silva, M A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bipolar disorder; Dopamine; Flow cytometry; Leukocytes; NCS 1; Schizophrenia

Indexed keywords

ARACHIDONIC ACID; BIPERIDEN; CD19 ANTIBODY; CD56 ANTIGEN; CHLORPROMAZINE; CLONAZEPAM; DIAZEPAM; DOPAMINE; DOPAMINE 2 RECEPTOR; FLUPHENAZINE; HALOPERIDOL; IMIPRAMINE; IMMUNOGLOBULIN FC FRAGMENT; ION CHANNEL; LAMOTRIGINE; LEVOMEPROMAZINE; LORAZEPAM; MESSENGER RNA; MIDAZOLAM; NEURONAL CALCIUM SENSOR; OLANZAPINE; PROMETHAZINE; RISPERIDONE; THIORIDAZINE; VALPROIC ACID; VENLAFAXINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; BIPOLAR DISORDER; CD4+ T LYMPHOCYTE; COMORBIDITY; CONTROLLED STUDY; DESENSITIZATION; EXOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LEUKOCYTE; LYMPHOCYTE; MALE; MANIA; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NERVE CELL; NERVOUS SYSTEM; NEUROSECRETORY CELL; NEUROTRANSMISSION; NEUTROPHIL; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIZOPHRENIA;

ADULT; AGED; ANTIGENS, CD14; ANTIGENS, CD19; ANTIGENS, CD56; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES; MALE; MIDDLE AGED; MONOCYTES; NEURONAL CALCIUM-SENSOR PROTEINS; NEUROPEPTIDES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 60049101435     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.11.011     Document Type: Article

References (46)

1. Bai J., He F., Novikova S.I., Undie A.S., Dracheva S., Haroutunian V., et al. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biol Psychiatry 15 (2004) 427-440
2. Brochetta C., Perrotta M.G., Jeromin A., Romano M., Vita F., Soranzo M.R., et al. Identification and subcellular localization of neuronal calcium sensor-1 (NCS-1) in human neutrophils and HL-60 cells. Inflammation 27 (2003) 361-372
3. Burgoyne R.D., and Weiss J.L. The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J 353 (2001) 1-12
4. Centorrino F., Eakin M., Bahk W.M., Kelleher J.P., Goren J., Salvatore P., Egli S., and Baldessarini R.J. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry 159 (2002) 1932-1935
5. Dickinson D., Ragland J.D., Gold J.M., and Gur R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David?. Biol Psychiatry 64 (2008) 823-827
6. Du X., Tang Y., Xu H., Lit L., Walker W., Ashwood P., et al. Genomics. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics 87 (2006) 693-703
7. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., and Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36 (2004) 131-137
8. Gao K., Gajwani P., Elhaj O., and Calabrese J.R. Typical and atypical antipsychotics in bipolar depression. J Clin Psychiatry 66 (2005) 1376-1385
9. Gladkevich A., Kauffman H.F., and Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuro-psychopharmacol Biol Psychiatry 28 (2004) 559-576
10. Gomez M., De Castro E., Guarin E., Sasakura H., Kuhara A., Mori I., et al. Ca2+ signaling via the neuronal calcium sensor-1 regulates associative learning and memory in C. elegans. Neuron 30 (2001) 241-248
11. Goodwin F.K., and Jamison K.R. Manic-depressive illness (1990), Oxford University Press, New York
12. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull 26 (2000) 119-136
13. Hilfiker S. Neuronal calcium sensor-1: a multifunctional regulator of secretion. Biochem Soc Trans 31 (2003) 828-832 [Review]
14. Horacek J., Bubenikova-Valesova V., Kopecek M., Palecinek T., Dockery C., Mohr P., et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20 (2006) 389-409
15. Kabbani N., Negyessy L., Lin R., Goldman-Rakic P., and Levenson R. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22 (2002) 8476-8486
16. Kapp-Barnea Y., Melnikov S., Shefler I., Jeromin A., and Sagi-Eisenberg R. Neuronal calcium sensor-1 and phosphatidylinositol 4-kinase beta regulate IgE receptor-triggered exocytosis in cultured mast cells. J Immunol 171 (2003) 5320-5327
17. Keefe R.S., Bilder R.M., Harvey P.D., Davis S.M., Palmer B.W., Gold J.M., et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31 (2006) 2033-2046
18. Kessler R.C., Chiu W.T., and Demler O. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the NationalComorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 62 (2005) 617-627
19. Koh P.O., Undie A.S., Kabbani N., Levenson R., Goldman-Rakic P.S., and Lidow M.S. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A 100 (2003) 313-317
20. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, Tsuang MT, Salomon DR, Nurnberger JI Jr, Niculescu AB. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry in press [26 Feb 2008, Electronic publication ahead of print].
21. Leucht S., Kane J.M., Kissling W., Hamann J., Etschel E., and Engel R.R. What does the PANSS mean?. Schizophr Res 79 (2005) 231-238
22. Manji H.K., and Lenox R.H. Signaling: cellular insights into pathophysiology of bipolar disorder. Biol Psychiatry 48 (2000) 518-530
23. 2+ sensor 1, the mammalian homologue of frequenin, is expressed in chromaffin and PC12 cells and regulates neurosecretion from dense-core granules. J Biol Chem 273 (1998) 22768-22772
24. McGurk S.R., Mueser K.T., Harvey P.D., LaPuglia R., and Marder J. Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatr Ser 54 (2003) 1129-1135
25. Mehler-Wex C., Duvigneau J.C., Hartl R.T., Ben-Shachar D., Warnke A., and Gerlach M. Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia?. Eur Child Adolesc Psychiatry 15 (2006) 504-507
26. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., and Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115 (2005) 289-295
27. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
28. Na K.S., and Kim Y.K. Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 56 (2007) 55-63
29. Nakamura T.Y., Jeromin A., Smith G., Kurushima H., Koga H., Nakabeppu Y., et al. Novel role of neuronal Ca2+ sensor-1 as a survival factor up-regulated in injured neurons. J Cell Biol 172 (2006) 1081-1091
30. Nef S., Fiumelli H., de Castro E., Raes M.B., and Nef P. Identification of neuronal calcium sensor (NCS-1) possibly involved in the regulation of receptor phosphorylation. J Recept Signal Transduct Res 15 (1995) 365-378
31. Kapp-Barnea Y., Ninio-Many L., Hirschberg K., Fukuda M., Jeromin A., and Sagi-Eisenberg R. Neuronal calcium sensor-1 and phosphatidylinositol 4-kinase beta stimulate extracellular signal-regulated kinase 1/2 signaling by accelerating recycling through the endocytic recycling compartment. Mol Biol Cell 17 (2006) 4130-4141
32. O'Callaghan D.W., and Burgoyne R.D. Role of myristoylation in the intracellular targeting of neuronal calcium sensor (NCS) proteins. Biochem Soc Transac 31 (2003) 963-965
33. Olafsson P., Soares H.D., Herzog K.H., Wang T., Morgan J.I., and Lu B. The Ca2+ binding protein, frequenin is a nervous system-specific protein in mouse preferentially localized in neurites. Brain Res Mol Brain Res 44 (1997) 73-82
34. Ortiz-Domínguez A., Hernández M.E., Berlanga C., Gutiérrez-Mora D., Moreno J., Heinze G., et al. Immune variations in bipolar disorder: phasic differences. Bipolar Disord 9 (2007) 596-602
35. Pellicano C., Buttarelli F.R., Circella A., Tiple D., Giovannelli M., Benincasa D., et al. Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor. J Neural Transm 114 (2007) 935-938
36. Torres KC, Souza BR, Miranda DM, Nicolato R, Neves FS, Barros AG, Dutra WO, Gollob KJ, Correa H, Romano-Silva MA. The leukocytes expressing DARPP-32 is reduced in patients with schizophrenia and bipolar disorder. PNBP; in press [8 Nov 2008, Electronic pulication ahead of print].
37. Reis H.J., Rosa D.V., Guimares M.M., Souza B.R., Barros A.G., Pimenta F.J., et al. Is NCS-1 a potential therapeutic target?. Expert Opin Ther Targets 11 (2007) 1649-1661 Review
38. Sagi-Eisenberg R. The mast cell: where endocytosis and regulated exocytosis meet. Immunol Rev 217 (2007) 292-303 Review
39. Seeman P., Schwarz J., Chen J.F., Szechman H., Perreault M., McKnight G.S., et al. Psychosis pathways converge via D2high dopamine receptors. Synapse 60 (2006) 319-346
40. Souza R.P., Rosa D.V., Souza B.R., and Romano-Silva M. NCS-1. AfCS-Nature Molecule Pages (2006) 10.1038/mp.a000752.01
41. Souza B.R., Motta B.S., Rosa D.V., Torres K.C., Castro A.A., Comim C.M., Sampaio A.M., Lima F.F., Jeromin A., Quevedo J., and Romano-Silva M.A. DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics. Neurochem Res 33 (2008) 533-538
42. Teixeira A.L., Helton J.R., Nicolato R., Brito-Melo G., Correa H., Teixeira M.M., et al. Increased serum levels of CCL11/eotaxin in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 32 (2008) 710-714
43. Torres K.C., Antonelli L.R., Souza A.L., Teixeira M.M., Dutra W.O., and Gollob K.J. Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol 166 (2005) 144-157
44. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (2003) 663-667
45. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
46. Zucker R.S. NCS-1 stirs somnolent synapses. Nat Neurosci 6 (2003) 1006-1008